@article{article, title  = {{Pazopanib versus paclitaxel in relapsed urothelial tumors: A randomized phase II study investigating pazopanib versus weekly paclitaxel in relapsed or progressive transitional cell carcinoma of the urothelium (PLUTO).}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://doi.org/10.1200/jco.2014.32.15_suppl.tps4589 }},

 year = {{2014}},

 month = {{5}},

 author = {{Jones RJ and Chester JD and Dixon-Hughes J and Alexander L and Bahl A and Hussain SA and Birtle A and Jagdev S and Morris A and Stobo J and Bray CA et al}},

 doi = {{10.1200/jco.2014.32.15_suppl.tps4589}},

 volume = {{32}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{TPS4589-TPS4589}},

 note = {{Accessed on 2025/12/05}}}